Latest Soft tissue sarcoma Stories
Oral presentation (abstract 10503) featured at the Annual Meeting of the American Society of Clinical Oncology CHICAGO and RARITAN, N.J., June 1, 2015 /PRNewswire/ -- Janssen Research
SAN DIEGO, June 1, 2015 /PRNewswire/ -- OncoSec Medical Inc.
Data from pivotal study for eribulin to be presented during oral session at the American Society of Clinical Oncology (ASCO) Annual Meeting WOODCLIFF LAKE, N.J., May 30, 2015 /PRNewswire/ --
LOS ANGELES, May 1, 2015 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months
National Cancer Institute Clinical Trial for TRC105 for Angiosarcoma Santa Monica, Ca (PRWEB) April 30, 2015 The Sarcoma Oncology Center is participating
Eisai Demonstrates Commitment to Patients with Rare Cancers WOODCLIFF LAKE, N.J., Feb. 25, 2015 /PRNewswire/ -- Eisai Inc.
MADRID, February 3, 2015 /PRNewswire/ -- PharmaMar announces that the U.S.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
Aldoxorubicin Demonstrates 2-Fold Increase in Likelihood of Surviving More than 2 Years versus Doxorubicin and 27% Reduction in the Risk of Death LOS ANGELES, Jan.
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.